Celecoxib Versus Diclofenac for the Treatment of Ankylosing Spondylitis: 12-Week Randomized Study in Norwegian Patients

Journal of International Medical Research - United Kingdom
doi 10.1177/0300060516628704
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Prospects for the Use of Celecoxib in Patients With Ankylosing Spondylitis: Impact on Retarding Disease Progression

Modern Rheumatology Journal
2012English

Pms42 - Secukinumab Versus Adalimumab for the Treatment of Ankylosing Spondylitis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Straightening Out Treatment Recommendations for Ankylosing Spondylitis

Pharmacy Today
2016English

The Treatment of Spinal Pseudarthrosis in Ankylosing Spondylitis

Journal of the Korean Orthopaedic Association
2005English

Golimumab Administered Subcutaneously Every 4 Weeks in Ankylosing Spondylitis: 104-Week Results of the GO-RAISE Study

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

TNF-alpha Antagonists for Treatment of Juvenile Ankylosing Spondylitis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Detection of Chlamydia Pneumoniae in Ankylosing Spondylitis Patients

Baghdad Science Journal
AstronomyGeneticsMolecular BiologyBiochemistryMathematicsComputer ScienceBiological SciencesAgriculturalChemistryPhysics
2018English

Ankylosing Spondylitis

2019English

Ankylosing Spondylitis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy